This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Over the long term, broad indices tend to outperform many active strategies due to lower costs and market-wide diversification.
27,915 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Amazon's liquidity position is tightening as it pours billions into AI infrastructure. Investors pore over cash metri...
A viral moment about who understands scripture isn’t just a religious debate. It carried real implications for how pe...
Westport's Q4 2025 earnings release offers clues about growth, margins, and cash flow. This article breaks down the t...
When a tech titan steps into AI, markets listen. This article explains why apple just joined revolution could reshape...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Nike's quarterly results offer more than sneaker news. This guide breaks down the numbers, the stock reaction, and ac...
Meta is testing a bold cloud strategy that could reshape its growth trajectory. This article breaks down how leasing ...
Dividend income investors watch yields closely. This article explains how yields move, why this dividend ETF's yield ...
SpaceX plans to push Starship through another high-stakes test flight. Here’s what investors should watch, how it cou...
As whispers of an OpenAI IPO grow louder, investors must ask: is openai going public wrong for reasons that could der...
A surprise rally in Kingsoft Cloud Holdings stock grabbed attention as analysts spotlight AI-driven growth. This arti...